[PDF][PDF] Coupling of homologous recombination and the checkpoint by ATR

R Buisson, J Niraj, A Rodrigue, CK Ho, J Kreuzer… - Molecular cell, 2017 - cell.com
R Buisson, J Niraj, A Rodrigue, CK Ho, J Kreuzer, TK Foo, EJL Hardy, G Dellaire, W Haas
Molecular cell, 2017cell.com
ATR is a key regulator of cell-cycle checkpoints and homologous recombination (HR).
Paradoxically, ATR inhibits CDKs during checkpoint responses, but CDK activity is required
for efficient HR. Here, we show that ATR promotes HR after CDK-driven DNA end resection.
ATR stimulates the BRCA1-PALB2 interaction after DNA damage and promotes PALB2
localization to DNA damage sites. ATR enhances BRCA1-PALB2 binding at least in part by
inhibiting CDKs. The optimal interaction of BRCA1 and PALB2 requires phosphorylation of …
Summary
ATR is a key regulator of cell-cycle checkpoints and homologous recombination (HR). Paradoxically, ATR inhibits CDKs during checkpoint responses, but CDK activity is required for efficient HR. Here, we show that ATR promotes HR after CDK-driven DNA end resection. ATR stimulates the BRCA1-PALB2 interaction after DNA damage and promotes PALB2 localization to DNA damage sites. ATR enhances BRCA1-PALB2 binding at least in part by inhibiting CDKs. The optimal interaction of BRCA1 and PALB2 requires phosphorylation of PALB2 at S59, an ATR site, and hypo-phosphorylation of S64, a CDK site. The PALB2-S59A/S64E mutant is defective for localization to DNA damage sites and HR, whereas the PALB2-S59E/S64A mutant partially bypasses ATR for its localization. Thus, HR is a biphasic process requiring both high-CDK and low-CDK periods. As exemplified by the regulation of PALB2 by ATR, ATR promotes HR by orchestrating a "CDK-to-ATR switch" post-resection, directly coupling the checkpoint to HR.
cell.com